发布: 2019年08月05日第9卷第15期 DOI: 10.21769/BioProtoc.3317 浏览次数: 5623
评审: Meenal SinhaLuis Alberto Sánchez VargasAnonymous reviewer(s)
Abstract
Splenectomy in an animal model requires a standardized technique utilizing best practice to avoid variability which can result in adverse impact to the animal resulting in flawed physiologic responses simply due to technique rather than to the studied variables. In the case of the spleen, often investigators are analyzing the animal immune or inflammatory responses. Surgical splenectomy involves many variables from the training and expertise of the surgeon, which directly correlates to surgical technique to the length of operation and ease of the procedure. This operation, in turn, impacts blood loss and insensible fluid losses, sterile technique, unintended trauma to the spleen and surrounding organs, the length of the incision and the duration of the operation with more prolonged exposure to anesthetic agents. All these variables ultimately play a significant role in the experiment since they directly affect the response of the model in terms of inflammation, immune activation, or even suppression. Undesired variables such as these go unnoticed and lead to inaccurate and misleading data.
Keywords: Blunt trauma (钝性创伤)Background
The spleen produces protective humoral antibodies via plasma cells, harbors transient and stable populations of B and T cells, filters particulate antigens, and is a reservoir for red and white blood cells. There are specific helper T cells that migrate to and from the spleen serving a role in tumor surveillance and antigen recognition. It has also long been recognized as a domicile for specific B cell populations affecting the individual’s ability to respond to specific gram-negative encapsulated bacteria such as Meningococcus, Streptococcus, and Haemophilus. Splenectomy is sometimes necessary in cases of hemolytic anemias with splenomegaly from hereditary spherocytosis or sickle cell disease or in cases of thrombocytopenia, trauma, and even in some instances of malaria. In many instances, pediatric surgeons try to preserve some splenic function to preserve some immune function and avert long term risks of pulmonary hypertension by performing a partial splenectomy saving about 20-30% of the total splenic mass (Tastaldi et al., 2019). Sometimes due to the inadequate vascular supply of the upper pole of the spleen or in cases of hilar involvement of lesions or massive trauma, total splenectomy may be the only option. Asplenia may result in increased risks of post-splenectomy sepsis, pulmonary hypertension and even some speculation of increased risk of Type II diabetes, childhood obesity (Szendroi et al., 1997) and even inadequate cellular repair responses after cardiac ischemia (Costi et al., 2018).
Recent reports show that therapeutic modality for efficient antigen delivery to spleen shows promising for conquering tumor growth and progression (Shimizu et al., 2018). Current immunotherapy elevated the splenic level of IL-1β, IL-4, IL-10, IL-17, IFN-γ, and TNF-α for immunomodulatory effects of cancer progression (Merheb et al., 2019). Pediatric surgeons have advanced laparoscopic partial splenectomy to preserve hematological functions of the organ while trying to blunt or ameliorate hemolytic dysfunction (Serra et al., 2018). All these studies require the optimal performance of splenectomy to gain immune benefits of spleen function.
Surgery for splenectomy can involve many variables from training and expertise of the surgeon, surgical technique, length of operation, ease of the procedure, blood and fluid loss, sterile technique, trauma to the spleen or other tissues and traumatic manipulation, length of incision and length of exposure to anesthetic agents.
We provide some guidelines for the standardization of the technique for splenectomy and some thoughts in order to create a procedural best practice protocol such that resulting data can have less contamination by factors that can truly impact the right metrics being evaluated such as the degree of inflammation or immunity.
Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2019 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Readers should cite both the Bio-protocol article and the original research article where this protocol was used:
分类
免疫学 > 动物模型 > 小鼠
微生物学 > 体内实验模型 > 细菌
细胞生物学 > 组织分析 > 损伤模型
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link




